Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ)

CNY 17.05

(3.9%)

Revenue Summary of Nanjing Hicin Pharmaceutical Co., Ltd.

  • Nanjing Hicin Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 517.83 Million CNY , down -3.78% from previous year.
  • Nanjing Hicin Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q1 was 102.14 Million CNY , down -25.43% from previous quarter.
  • Nanjing Hicin Pharmaceutical Co., Ltd. reported a annual revenue of 526.46 Million CNY in annual revenue 2022, down -8.97% from previous year.
  • Nanjing Hicin Pharmaceutical Co., Ltd. reported a annual revenue of 578.31 Million CNY in annual revenue 2021, down -18.12% from previous year.
  • Nanjing Hicin Pharmaceutical Co., Ltd. reported a quarterly revenue of 102.14 Million CNY for 2024 Q1, down -25.43% from previous quarter.
  • Nanjing Hicin Pharmaceutical Co., Ltd. reported a quarterly revenue of 129.02 Million CNY for 2024 Q2, up 26.31% from previous quarter.

Annual Revenue Chart of Nanjing Hicin Pharmaceutical Co., Ltd. (2023 - 2012)

Historical Annual Revenue of Nanjing Hicin Pharmaceutical Co., Ltd. (2023 - 2012)

Year Revenue Revenue Growth
2023 517.83 Million CNY -3.78%
2022 526.46 Million CNY -8.97%
2021 578.31 Million CNY -18.12%
2020 706.29 Million CNY -23.61%
2019 924.53 Million CNY 29.87%
2018 711.9 Million CNY 56.45%
2017 455.03 Million CNY 62.03%
2016 280.82 Million CNY 27.08%
2015 220.99 Million CNY 11.81%
2014 197.65 Million CNY 16.61%
2013 169.5 Million CNY 14.56%
2012 147.95 Million CNY 0.0%

Peer Revenue Comparison of Nanjing Hicin Pharmaceutical Co., Ltd.

Name Revenue Revenue Difference
Shenzhen Neptunus Bioengineering Co., Ltd. 36.41 Billion CNY 98.578%
Anhui Fengyuan Pharmaceutical Co., Ltd. 4.27 Billion CNY 87.888%
Dong-E-E-Jiao Co.,Ltd. 4.71 Billion CNY 89.018%
Livzon Pharmaceutical Group Inc. 12.27 Billion CNY 95.783%
Hainan Haiyao Co., Ltd. 1.45 Billion CNY 64.464%
Tus-Pharmaceutical Group Co., Ltd. 395.92 Million CNY -30.791%
Jilin Aodong Pharmaceutical Group Co., Ltd. 3.44 Billion CNY 84.987%
Changchun High-Tech Industries (Group) Inc. 14.46 Billion CNY 96.419%
Apeloa Pharmaceutical Co.,Ltd 11.47 Billion CNY 95.487%
PKU HealthCare Corp.,Ltd. 2.19 Billion CNY 76.396%
Chengdu Huasun Technology Group Inc., Ltd. 1 Billion CNY 48.391%
Dezhan Healthcare Company Limited 498.08 Million CNY -3.964%
Jinling Pharmaceutical Company Limited 2.78 Billion CNY 81.411%
Jiuzhitang Co., Ltd. 2.91 Billion CNY 82.262%
Huapont Life Sciences Co., Ltd. 11.59 Billion CNY 95.534%
Zhejiang Jingxin Pharmaceutical Co., Ltd. 3.95 Billion CNY 86.897%
Shandong Wohua Pharmaceutical Co., Ltd. 894.31 Million CNY 42.097%
Hengkang Medical Group Co., Ltd. 3.59 Billion CNY 85.578%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 2.61 Billion CNY 80.164%
Qianjiang Yongan Pharmaceutical Co., Ltd. 962.8 Million CNY 46.216%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 5.42 Billion CNY 90.449%
Jinhe Biotechnology CO., LTD. 2.17 Billion CNY 76.182%
Teyi Pharmaceutical Group Co.,Ltd 1.06 Billion CNY 51.478%
Kunming Longjin Pharmaceutical Co., Ltd. 86.62 Million CNY -497.803%
Beijing Aosaikang Pharmaceutical Co., Ltd. 1.44 Billion CNY 64.126%
Chengdu Kanghong Pharmaceutical Group Co., Ltd 3.95 Billion CNY 86.915%
Anhui Huangshan Capsule Co., Ltd. 458.36 Million CNY -12.973%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd 980.82 Million CNY 47.205%
Zhuhai Rundu Pharmaceutical Co., Ltd. 1.29 Billion CNY 59.917%
Huaren Pharmaceutical Co., Ltd. 1.63 Billion CNY 68.353%
Tianjin Ringpu Bio-Technology Co.,Ltd. 2.24 Billion CNY 76.975%
Shanxi Zhendong Pharmaceutical Co.,Ltd 3.62 Billion CNY 85.719%
Fuan Pharmaceutical (Group) Co., Ltd. 2.64 Billion CNY 80.443%
Hybio Pharmaceutical Co., Ltd. 431.38 Million CNY -20.04%
Baotou Dongbao Bio-Tech Co.,Ltd 974.51 Million CNY 46.862%
Hunan Er-Kang Pharmaceutical Co., Ltd 1.76 Billion CNY 70.731%
Changjiang Pharmaceutical Group Co., Ltd. 1.19 Billion CNY 56.759%
Zhejiang Garden Bio-chemical High-tech Co., Ltd. 1.09 Billion CNY 52.694%
Fujian Cosunter Pharmaceutical Co., Ltd. 422.71 Million CNY -22.502%
Beijing Science Sun Pharmaceutical Co., Ltd. 476.56 Million CNY -8.658%
Zhejiang Xinguang Pharmaceutical Co., Ltd. 270.39 Million CNY -91.506%
Hainan Poly Pharm. Co., Ltd 1.3 Billion CNY 60.304%
Jiangxi Synergy Pharmaceutical Co., Ltd. 722.13 Million CNY 28.292%
Wuhan Hiteck Biological Pharma Co.,Ltd 602.28 Million CNY 14.022%
Shandong Xinhua Pharmaceutical Company Limited 8 Billion CNY 93.534%
Zhejiang Tianyu Pharmaceutical Co., Ltd. 2.52 Billion CNY 79.51%
PharmaBlock Sciences (Nanjing), Inc. 1.72 Billion CNY 69.984%
Jinghua Pharmaceutical Group Co., Ltd. 1.49 Billion CNY 65.257%
Zhejiang Hisoar Pharmaceutical Co., Ltd. 2.17 Billion CNY 76.157%
Betta Pharmaceuticals Co., Ltd. 2.45 Billion CNY 78.917%
Tibet AIM Pharm. Inc. 667.03 Million CNY 22.369%
Shenzhen Kangtai Biological Products Co., Ltd. 3.47 Billion CNY 85.109%
Shandong Shanda Wit Science and Technology Co., Ltd. 2.48 Billion CNY 79.155%
Pacific Shuanglin Bio-pharmacy Co., LTD 2.32 Billion CNY 77.763%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. 1.62 Billion CNY 68.15%
Xiamen Kingdomway Group Company 3.1 Billion CNY 83.31%
ShanXi C&Y Pharmaceutical Group Co., Ltd. 799.3 Million CNY 35.215%
Walvax Biotechnology Co., Ltd. 4.11 Billion CNY 87.412%
Sunflower Pharmaceutical Group Co.,Ltd 5.63 Billion CNY 90.805%
Harbin Gloria Pharmaceuticals Co., Ltd 2.58 Billion CNY 80.006%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 24.73 Billion CNY 97.907%
Hunan Hansen Pharmaceutical Co., Ltd. 955.53 Million CNY 45.807%
Changzhou Qianhong Biopharma CO.,LTD 1.79 Billion CNY 71.133%
Shenzhen Weiguang Biological Products Co., Ltd. 1.04 Billion CNY 50.612%
Honz Pharmaceutical Co., Ltd. 739.56 Million CNY 29.982%
Northeast Pharmaceutical Group Co., Ltd. 8.16 Billion CNY 93.655%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd 1.46 Billion CNY 64.597%
Guizhou Xinbang Pharmaceutical Co., Ltd. 6.46 Billion CNY 91.985%
Tianjin Lisheng Pharmaceutical Co.,Ltd. 1.13 Billion CNY 54.181%
Zhejiang Yatai Pharmaceutical Co., Ltd. 420.64 Million CNY -23.105%
Zhejiang NHU Company Ltd. 15.11 Billion CNY 96.574%
ApicHope Pharmaceutical Co., Ltd 2.5 Billion CNY 79.315%
Shanghai Kaibao Pharmaceutical CO.,Ltd 1.59 Billion CNY 67.515%
Beijing SL Pharmaceutical Co., Ltd. 1.01 Billion CNY 49.15%
Yunnan Baiyao Group Co.,Ltd 38.9 Billion CNY 98.669%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD 1.08 Billion CNY 52.055%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. 839.25 Million CNY 38.299%
Guangdong Lifestrong Pharmacy Co., Ltd. 292.39 Million CNY -77.099%
Huadong Medicine Co., Ltd 40.39 Billion CNY 98.718%
Jiangsu Nhwa Pharmaceutical Co., LTD 4.97 Billion CNY 89.588%
Harbin Medisan Pharmaceutical Co., Ltd. 1.18 Billion CNY 56.367%
LanZhou Foci Pharmaceutical Co.,Ltd. 1.16 Billion CNY 55.48%
Tianjin Chase Sun Pharmaceutical Co.,Ltd 6.12 Billion CNY 91.549%
Beijing Beilu Pharmaceutical Co., Ltd 890.71 Million CNY 41.864%
Renhe Pharmacy Co., Ltd. 5.03 Billion CNY 89.71%
Chongqing Pharscin Pharmaceutical Co., Ltd. 691.54 Million CNY 25.119%
Zhejiang Xianju Pharmaceutical Co.,Ltd. 4.12 Billion CNY 87.442%
Luoxin Pharmaceuticals Group Stock Co., Ltd. 2.34 Billion CNY 77.895%
Guizhou Bailing Group Pharmaceutical Co., Ltd. 4.26 Billion CNY 87.853%